United Therapeutics Corp
XNAS: UTHR
United Therapeutics Corp Live Stock Price Today, Share Analysis and Chart
about
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...
Read More
405.02
0.18
(0.04%)
626.4K
XNAS Volume
XNAS 12 Sep, 2025 5:30 PM (EDT)
Insider Trade
Martine Rothblatt, Chairperson & CEO of United Therapeutics, sells 8K shares worth $3.2 million
See details
Medium Financial Strength
Mid Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors.
View Similar
Embed DVM
United Therapeutics Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..